Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Express Scripts
US Department of Justice
Citi
Boehringer Ingelheim
Queensland Health
Federal Trade Commission
Farmers Insurance
Baxter
Accenture

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021037

« Back to Dashboard

NDA 021037 describes MAGNEVIST, which is a drug marketed by Bayer Hlthcare and is included in two NDAs. It is available from two suppliers. Additional details are available on the MAGNEVIST profile page.

The generic ingredient in MAGNEVIST is gadopentetate dimeglumine. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the gadopentetate dimeglumine profile page.
Summary for 021037
Tradename:MAGNEVIST
Applicant:Bayer Hlthcare
Ingredient:gadopentetate dimeglumine
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021037
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037 NDA AUTHORIZED GENERIC Alvogen, Inc 47781-147 N 47781-147-27
MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037 NDA AUTHORIZED GENERIC Alvogen, Inc 47781-147 N 47781-147-29

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength469.01MG/ML
Approval Date:Mar 10, 2000TE:RLD:Yes

Expired US Patents for NDA 021037

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ➤ Sign Up ➤ Sign Up
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ➤ Sign Up ➤ Sign Up
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ➤ Sign Up ➤ Sign Up
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ➤ Sign Up ➤ Sign Up
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Farmers Insurance
Moodys
Colorcon
Federal Trade Commission
McKinsey
Citi
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot